Markets & Money News

Nuvama Backs IT, PSU Banks and Pharma for Samvat 2083: What Savers Should Know

Brokerage Nuvama sees a re-rating chance in Samvat 2083, with IT, PSU banks and pharma in focus. Here's what that means for your savings and SIPs.

Raashi Sharma Written by Raashi Sharma

Sugandha Jha Reviewed by Sugandha Jha

Published:

Updated:

Nuvama Backs IT, PSU Banks and Pharma for Samvat 2083: What Savers Should Know

Nuvama, a brokerage firm, sees a chance for Indian stocks to be re-rated in Samvat 2083. That's according to reporting by Moneycontrol.com. It's putting IT, PSU banks and pharma in focus. Samvat is the Hindu new year that many traders follow, and it starts around Diwali.

For you, this is one firm's view, not a promise. If you invest, it may shape how you spread your money. If you borrow or save, it changes very little this week.

Key takeaways

  • Nuvama sees a re-rating chance in Samvat 2083, as reported by Moneycontrol.com.
  • IT, PSU banks and pharma are the sectors in focus.
  • Re-rating means investors may pay more for the same profit.
  • A brokerage view isn't a guarantee, so don't put all your money in three sectors.
  • Clearing costly debt and keeping an emergency fund still come first.

What does re-rating mean in simple terms?

Imagine a shop that earns ₹10 profit. One buyer pays ₹100 for it. Later, another buyer pays ₹150 for the same shop. The profit didn't change, but the price did. That's a re-rating.

In the stock market, it happens when investors feel more hopeful about a company or sector. They then pay more for each rupee of profit. It can also go the other way. Prices can fall when hope fades.

The headline suggests Nuvama thinks IT, PSU banks and pharma could see that kind of shift. We don't have the firm's targets or reasons, so we won't guess them.

What changes for savers and borrowers?

Most families don't buy single sectors. They own mutual funds, often through a SIP. A SIP is a fixed amount you invest every month. Many broad funds already hold IT, bank and pharma shares.

Here's a simple example. You put ₹5,000 a month in a SIP for 10 years. That's ₹6,00,000 invested. The final value depends on the return you get. These numbers are only illustrations, not forecasts.

Yearly return (assumed) Amount you put in Approx. value after 10 years
6% ₹6,00,000 ₹8.2 lakh
10% ₹6,00,000 ₹10.4 lakh
12% ₹6,00,000 ₹11.6 lakh

See how the return you get matters a lot? Yet your steady monthly habit matters even more. A sector call can't replace that habit.

If you borrow, this news doesn't change your EMI. Loan rates depend on RBI policy and your lender, not on brokerage views. You can check today's rates on our interest rates page.

Who is affected?

New and small investors feel this most. A bold sector call can pull people into buying at a high price. That's when losses hurt.

People who own PSU bank shares may feel more hopeful. But if you only keep money in a PSU bank account or FD, nothing changes. Your deposit is separate from the bank's share price. Deposits are also insured up to ₹5 lakh per person per bank by DICGC.

People with loans are affected in a different way. If you plan to borrow to invest, please stop and think. A personal loan can cost 11% to 24% a year. Market returns are never certain. That's a risky mismatch.

What to do now

You don't need to act just because of a headline. A calm checklist works better:

  1. Keep three to six months of expenses in a safe place as an emergency fund.
  2. Pay off any loan that costs more than you can hope to earn.
  3. Check what your current mutual funds already hold.
  4. Keep your SIP running, and raise it a little each year if you can.
  5. Never put more than you can afford to lose into one theme.

For more market and money stories, visit our news hub.

Frequently asked questions

What does Samvat 2083 mean for my investments?

Samvat 2083 is just the new Hindu year that traders follow from Diwali. It doesn't change your SIP or FD by itself. It's more of a fresh-start point for reviewing your plan.

Should I buy IT, PSU bank or pharma stocks now?

That's a personal choice, and no one can promise a gain. If you do invest, keep it a small part of your money. Consider speaking to a SEBI-registered adviser first.

Will this news change my loan EMI or FD rate?

No. Loan and FD rates follow RBI policy and bank decisions. A brokerage view on stocks doesn't move them.

BankCreds analysis

Don't let a sector call change your plan

A brokerage view is one opinion about one year. It isn't a rule. Brokerages also change their views often, and markets can go against them.

Here's the rupee side. Say you hold ₹5,000 a month in a SIP (a fixed monthly investment) in a broad fund. Moving it all into three sectors won't add a rupee on its own. It only adds risk. A diversified fund may already hold IT, bank and pharma shares.

The bigger gain for most homes is boring. Clear a loan charging 14% before chasing a stock idea that might give 12%. Paying off that debt is a sure return. A share tip is not.

This news matters most to people who already invest and want to rebalance. If you're new, the headline is less important than it sounds. Your savings habit matters more than the sector.

This section is BankCreds' own assessment of what the development means for Indian borrowers and savers. It is independent commentary, not part of the source reporting above.

Sources & references

  1. Moneycontrol.com — originating report https://www.moneycontrol.com/news/business/markets/samvat-2083-nuvama-sees-re-rating-opportunity-it-psu-banks-and-pharma-in-focus-14073451.html/amp
  2. DICGC deposit insurance — Bank deposits are insured up to ₹5 lakh per depositor per bank https://www.dicgc.org.in/
  3. SEBI — Regulator for mutual funds and stock markets in India https://www.sebi.gov.in/

Source links are shown as plain text, not clickable links. Copy a URL into your browser to read the original report.

Editorial note & disclaimer

How this was reported. The development above is attributed to the source or sources listed. BankCreds does not independently verify a third party's reporting; where a figure or a regulatory position is stated as fact, it is either attributed or drawn from the regulator's own published material. Everything under "BankCreds analysis" is our own assessment.

Rates and figures. Interest rates, per-gram values and premium bands quoted here are indicative, move daily, and differ by borrower profile, city and lender policy. Confirm the final number with the institution before you act on it — the sanction letter or policy schedule governs, not a news report.

Not financial advice. This article is general information for an Indian audience. It is not investment, tax, credit or insurance advice, takes no account of your circumstances, and BankCreds is not a lender, broker, distributor or advisor. Consider speaking to a SEBI-registered investment adviser or a qualified professional before acting.

Editorial policy · Fact-checking policy · Corrections policy · Our authors · About BankCreds · Contact us

Spotted an error? Corrections are published, not quietly edited — write to us via the contact page and see our corrections policy.

Never miss a rate move — get free alerts

Choose what you care about — every category, one loan type, or a daily gold-rate alert — and we deliver it to your inbox or phone.

Free forever, unsubscribe anytime. We only send what you pick — no spam, no sharing of your contact details.

Disclaimer: BankCreds.com is a loan comparison platform and does not directly lend, disburse, or provide any financial products. We aggregate and display loan offers from RBI-registered banks and NBFCs to help you make an informed decision. All loan applications are processed directly by the respective lender. Interest rates, charges, eligibility, and terms shown are indicative and subject to the lender's final assessment. Please read the lender's terms and conditions carefully before applying.